Executive Summary
Markets have navigated the "higher for longer" rate environment better than most expected entering 2025. Earnings growth has been the primary driver of equity returns rather than multiple expansion — a healthier setup than 2023. We remain constructively positioned but increasingly selective as valuations in mega-cap tech reach historically elevated levels.
The next 12 months will reward patient, selective investors. Broad index returns will likely be modest; the opportunity is in the divergence within sectors.
Rates & The Fed
The Federal Reserve held rates steady at 5.25–5.50% through Q1 2025, with futures markets now pricing just two cuts for the full year — a meaningful pullback from the six cuts priced at the start of 2024. Core PCE inflation remains sticky at 2.8%, above the 2% target.
Our base case: one to two 25bp cuts in H2 2025, triggered by a softening labor market rather than a collapse. The 10-year Treasury at 4.6% is pricing in this scenario fairly; we don't see a dramatic rate rally unless recession risks materialize.
What this means for investors: Short-duration bond funds and money market yields remain attractive at 5%+. Avoid extending duration aggressively into long-dated bonds until the Fed signals a clear cutting cycle.
Equity Valuations
The S&P 500 trades at ~23x forward earnings — elevated by historical standards but defensible if earnings growth of 10–12% is delivered. The problem is concentration: the "Magnificent 7" account for 31% of index weight and trade at an average of 38x forward earnings.
Equal-weighted S&P 500 (RSP) trades at ~17x — much closer to long-run fair value. This divergence creates selective opportunities in mid-cap, value, and international equities that are often overlooked.
Sector Views
Technology — Overweight (Selective)
AI infrastructure capex cycle has years to run. MSFT, NVDA, and AMZN remain high-conviction holdings. However, we trim exposure to software multiples above 20x revenue; the quality premium is already priced for many SaaS names.
Healthcare — Overweight
Aging demographics, GLP-1 drug revolution, and defensive characteristics make healthcare our preferred overweight. LLY and ISRG for growth; CVS for value. XLV ETF for broad exposure.
Energy — Neutral
Oil prices stabilized in the $75–85/bbl range. We see better risk/reward in clean energy infrastructure (VST, NEE) than traditional E&P at current commodity prices.
Financials — Overweight
Higher-for-longer rates continue to benefit NIM for banks. JPM and WFC are favorites. Regional banks remain a watch — credit quality metrics need another quarter of monitoring.
Consumer Discretionary — Underweight
Student loan repayment headwinds and credit card delinquency ticks upward suggest the consumer is bifurcating. High-income spending remains strong; middle-income is showing cracks.
Utilities — Neutral to Overweight
AI data center power demand is creating a once-in-a-generation tailwind for utilities. VST (merchant) is our preferred play; NEE for regulated exposure. Avoid pure regulated utilities without data center exposure.
Key Risks to Monitor
- Inflation re-acceleration: Any CPI print above 3.5% could trigger a repricing of rate cut expectations and a 10–15% correction in growth equities.
- Geopolitical escalation: Middle East or Taiwan Strait developments could spike oil and create supply chain disruptions.
- AI capex disappointment: If hyperscalers signal capex moderation in Q2 earnings calls, NVDA and related semis would reprice sharply.
- Election uncertainty: November 2025 fiscal policy uncertainty may keep investors defensive in H2.
Our Positioning
We recommend investors maintain a slight equity overweight (65–70% for balanced investors vs. the standard 60%) given positive earnings momentum, while keeping a larger-than-usual cash buffer (8–12%) to deploy on any 10%+ pullback. Focus on quality over momentum entering Q2.